Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
RedactPHI
HIPAA-Compliant PHI Redaction
DetectICD10CM
ICD-10-CM Code Detection
Log in Register free account
1 code page views remaining. Guest accounts are limited to 1 page view. Register free account to get 5 more views.
Log in Register free account
Code deleted, see 15271-15274

Official Description

Tissue cultured allogeneic dermal substitute, trunk, arms, legs; first 100 sq cm or less, or 1% of body area of infants and children

© Copyright 2025 American Medical Association. All rights reserved.

Common Language Description

A tissue cultured allogeneic dermal substitute is a specialized medical product used in the treatment of wounds or skin defects on the trunk, arms, or legs. This substitute is derived from human fibroblast cells, which are essential components of the skin that help in the formation of connective tissue. The fibroblasts are typically sourced from newborn foreskin tissue, ensuring a high level of viability and functionality. These cells are cultured and multiplied in a laboratory setting, where they are seeded onto a bioabsorbable mesh scaffold. This scaffold serves as a temporary structure that supports the fibroblasts as they grow and proliferate. As the fibroblasts multiply, they produce and secrete important substances such as human dermal collagen, matrix proteins, growth factors, and cytokines. These substances play a crucial role in wound healing and tissue regeneration by regulating the immune response and promoting the repair of damaged skin. The application of the dermal substitute involves careful preparation of the wound bed, followed by the placement of the substitute, which is then secured using sutures or staples to ensure it remains in position. After the dermal substitute is applied, a layered dressing is utilized to protect the area. This dressing typically consists of a nonadherent layer to prevent sticking to the wound, a bulky layer of gauze to absorb any exudate, a compression layer to support the area, and an anti-shear layer to minimize friction. The CPT® Code 15360 is specifically designated for the use of this dermal substitute when covering the first 100 square centimeters or less of skin area in adults, or up to 1% of the total body surface area in infants and children. For cases requiring additional coverage, CPT® Code 15361 is used for each subsequent 100 square centimeters or 1% of total body surface area.

© Copyright 2025 Coding Ahead. All rights reserved.

1. Indications

The tissue cultured allogeneic dermal substitute is indicated for use in various clinical scenarios where there is a need to cover wounds or skin defects on the trunk, arms, or legs. The following conditions may warrant the application of this procedure:

  • Wound Coverage The procedure is performed to provide coverage for acute or chronic wounds that require a biological substitute to promote healing.
  • Skin Defects It is indicated for the treatment of skin defects resulting from trauma, surgical procedures, or other medical conditions that compromise the integrity of the skin.
  • Burns The dermal substitute may be used in cases of partial-thickness burns where traditional wound care methods are insufficient for optimal healing.
  • Congenital Skin Conditions It is also indicated for infants and children with congenital skin conditions that necessitate dermal replacement therapy.

2. Procedure

The procedure for applying a tissue cultured allogeneic dermal substitute involves several critical steps to ensure effective treatment and optimal healing outcomes. The following procedural steps are outlined:

  • Preparation of the Wound Bed The first step involves thorough cleaning and debridement of the wound bed to remove any necrotic tissue, debris, or contaminants. This preparation is essential to create an optimal environment for the dermal substitute to adhere and integrate with the surrounding tissue.
  • Application of the Dermal Substitute Once the wound bed is adequately prepared, the tissue cultured allogeneic dermal substitute is carefully removed from its transport container. It is then positioned over the wound, ensuring complete coverage of the affected area. The substitute must be placed with precision to maximize contact with the wound bed.
  • Securing the Substitute After placement, the dermal substitute is secured in position using sutures or staples. This step is crucial to prevent displacement and to maintain the integrity of the substitute as it begins to integrate with the host tissue.
  • Application of Dressings Following the securement of the dermal substitute, a layered dressing is applied. This dressing typically consists of a nonadherent layer to prevent sticking to the wound, a bulky layer of gauze to absorb any exudate, a compression layer to provide support, and an anti-shear layer to minimize friction and protect the substitute from external forces.

3. Post-Procedure

Post-procedure care is essential to ensure proper healing and to monitor for any complications. After the application of the tissue cultured allogeneic dermal substitute, the patient should be advised on how to care for the dressing and the wound site. Regular follow-up appointments may be necessary to assess the healing process and to change the dressings as needed. It is important to monitor for signs of infection, such as increased redness, swelling, or discharge from the wound site. The healthcare provider may also provide specific instructions regarding activity restrictions to avoid undue stress on the healing area. Overall, the expected recovery will depend on the individual patient's condition and the extent of the wound being treated.

Short Descr APPLY CULT DERM SUB T/A/L
Medium Descr TISSUE CLTR ALGC DRM TRUNK/ARM/LEG 1ST 100 CM
Long Descr Tissue cultured allogeneic dermal substitute, trunk, arms, legs; first 100 sq cm or less, or 1% of body area of infants and children
Status Code Active Code
Global Days 090 - Major Surgery
PC/TC Indicator (26, TC) 0 - Physician Service Code
Multiple Procedures (51) 2 - Standard payment adjustment rules for multiple procedures apply.
Bilateral Surgery (50) 0 - 150% payment adjustment for bilateral procedures does NOT apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 1 - Statutory payment restriction for assistants at surgery applies to this procedure...
Co-Surgeons (62) 0 - Co-surgeons not permitted for this procedure.
Team Surgery (66) 0 - Team surgeons not permitted for this procedure.
Diagnostic Imaging Family 99 - Concept Does Not Apply
APC Status Indicator Discontinued Code
Type of Service (TOS) 2 - Surgery
Berenson-Eggers TOS (BETOS) P5A - Ambulatory procedures - skin
MUE Not applicable/unspecified.
CCS Clinical Classification 172 - Skin graft
Date
Action
Notes
2012-01-01 Deleted Code deleted, see 15271-15274
2011-01-01 Changed Short description changed.
2007-01-01 Changed Code description changed.
2006-01-01 Added Code added.
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"